Chemical Compound

Lopinavir Metabolite M-3/M-4

CAS Registry Number 357275-54-8
Back to search Request a Quote
Lopinavir Metabolite M-3/M-4 chemical structure
Primary Record

Lopinavir Metabolite M-3/M-4

In stock
6,118 g
Purity
99.6 %
CAS
357275-54-8

Compound Identifiers & Properties

CAS
357275-54-8
PubChem CID
486507
SMILES
CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCC(NC4=O)O)O
Canonical SMILES
Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCC(O)NC1=O

Names & Synonyms

  • Lopinavir Metabolite M-3/M-4
  • Lopinavir M-3/M-4
  • Lopinavir (m-3/m-4)
  • Lopinavir Metabolite
  • UNII-9BL5BH56JW
  • AC1LAEDB
  • 9BL5BH56JW
  • 357275-54-8
  • 4-HYDROXYLOPINAVIR
  • CHEMBL30207
  • orb1985834
  • Lopinavir M3/M4 metabolite(s)
  • SCHEMBL29831905
  • DTXSID40333147
  • AIDS108632
  • C37H48N4O6
  • GLXC-15406
  • BDBM50099843
  • CID486507
  • AKOS040752672
  • LOPINAVIR IMPURITY C [WHO-IP]
  • FL24928
  • M-3/M-4
  • DES(2-oxo-tetrahydropyrimidinyl)-2-oxo-4-hydroxy-tetrahydropyrimidinyl lopinavir
  • (2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-2-(4-hydroxy-2-oxo-1,3-diazinan-1-yl)-3-methylbutanamide
  • Q27272322
  • 1(2H)-Pyrimidineacetamide, N-((1S,3S,4S)-4-((2-(2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-4-hydroxy-alpha-(1-methylethyl)-2-oxo-, (alphaS)-
  • (2S)-N-[(1S,3S,4S)-1-benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-pentyl]-2-(4-hydroxy-2-oxo-hexahydropyrimidin-1-yl)-3-methyl-butanamide
  • 221553-72-6
  • (|AS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-4-hydroxy-|A-(1-methylethyl)-2-oxo-1(2H)-pyrimidine-acetamide
  • (2S)-N-((1S,3S,4S)-1-BENZYL-4-(((2,6-DIMETHYLPHENOXY)ACETYL)AMINO)-3-HYDROXY-5-PHENYLPENTYL)-2-((4RS)-4-HYDROXY-2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)-3-METHYLBUTANAMIDE
  • (2S)-N-{(2S,4S,5S)-5-[2-(2,6-Dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl}-2-(4-hydroxy-2-oxo-1,3-diazinan-1-yl)-3-methylbutanamide
  • (a-S)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-4-hydroxy-a-(1-methy lethyl)-2-oxo-1(2H)-pyrimidine-acetamide
  • (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-4-hydroxy-a-(1-methylethyl)-2-oxo-1(2H)-Pyrimidine-acetamid
  • (S)-N-[(S)-4-[2-(2,6-Dimethyl-phenoxy)-acetylamino]-3-(S)-hydroxy-5-phenyl-1-((S)-phenylmethyl)-pentyl]-2-(4-hydroxy-2-oxo-tetrahydro-pyrimidin-1-yl)-3-methyl-butyramide
  • (S)-N-{(1S,3S,4S)-1-Benzyl-4-[2-(2,6-dimethyl-phenoxy)-ethanoylamino]-3-hydroxy-5-phenyl-pentyl}-2-(4-hydroxy-2-oxo-tetrahydro-pyrimidin-1-yl)-3-methyl-butyramide
  • 1(2H)-PYRIMIDINEACETAMIDE, N-((1S,3S,4S)-4-((2-(2,6-DIMETHYLPHENOXY)ACETYL)AMINO)-3-HYDROXY-5-PHENYL-1-(PHENYLMETHYL)PENTYL)TETRAHYDRO-4-HYDROXY-.ALPHA.-(1-METHYLETHYL)-2-OXO-, (.ALPHA.S)-
  • 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-4-hydroxy-alpha-(1-methylethyl)-2-oxo-, (alphaS)-